The Role of Nanotechnology in Current COVID-19 Outbreak

Overview

Journal Heliyon

Specialty Social Sciences

Date 2021 Apr 21

PMID 33880422

Citations 9

Authors

Shima Tavakol

Masoumeh Zahmatkeshan

Reza Mohammadinejad

Saeed Mehrzadi

Mohammad T Joghataei

Mo S Alavijeh

Alexander Seifalian

Affiliations

Soon will be listed here.

Abstract

COVID-19 has recently become one of the most challenging pandemics of the last century with deadly outcomes and a high rate of reproduction number. It emphasizes the critical need for the designing of efficient vaccines to prevent virus infection, early and fast diagnosis by the high sensitivity and selectivity diagnostic kits, and effective antiviral and protective therapeutics to decline and eliminate the viral load and side effects derived from tissue damages. Therefore, non-toxic antiviral nanoparticles (NPs) have been under development for clinical application to prevent and treat COVID-19. NPs showed great promise to provide nano vaccines against viral infections. Here, we discuss the potentials of NPs that may be applied as a drug itself or as a platform for the aim of drug and vaccine repurposing and development. Meanwhile, the advanced strategies based on NPs to detect viruses will be described with the goal of encouraging scientists to design effective and cost-benefit nanoplatforms for prevention, diagnosis, and treatment.

Citing Articles

A systematic review of microneedles technology in drug delivery through a bibliometric and patent overview.

Cammarano A, Dello Iacono S, Battisti M, De Stefano L, Meglio C, Nicolais L Heliyon. 2024; 10(23):e40658.

PMID: 39669166 PMC: 11635707. DOI: 10.1016/j.heliyon.2024.e40658.

Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery.

Zacaron T, Silva M, Costa M, E Silva D, Silva A, Apolonio A Polymers (Basel). 2023; 15(18).

PMID: 37765701 PMC: 10536410. DOI: 10.3390/polym15183849.

New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention.

Solanki R, Shankar A, Modi U, Patel S Mater Today Chem. 2023; 29:101478.

PMID: 36950312 PMC: 9981536. DOI: 10.1016/j.mtchem.2023.101478.

Low-cost zeolitic carriers for delivery of hydroxychloroquine immunomodulatory agent with antiviral activity.

Olejnik A, Panek R, Madej J, Franus W, Goscianska J Microporous Mesoporous Mater. 2022; 346:112315.

PMID: 36407858 PMC: 9644156. DOI: 10.1016/j.micromeso.2022.112315.

Recent breakthroughs in nanostructured antiviral coating and filtration materials: a brief review.

Dahanayake M, Athukorala S, Jayasundera A RSC Adv. 2022; 12(26):16369-16385.

PMID: 35747530 PMC: 9158512. DOI: 10.1039/d2ra01567f.

References

Itani R, Tobaiqy M, Al Faraj A . Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients. Theranostics. 2020; 10(13):5932-5942. PMC: 7254986. DOI: 10.7150/thno.46691. View

Sexton N, Smith E, Blanc H, Vignuzzi M, Peersen O, Denison M . Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens. J Virol. 2016; 90(16):7415-7428. PMC: 4984655. DOI: 10.1128/JVI.00080-16. View

Qiu J, Cheng R, Zhang J, Sun H, Deng C, Meng F . Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia. Biomacromolecules. 2017; 18(10):3207-3214. DOI: 10.1021/acs.biomac.7b00846. View

Imperiale J, Schlachet I, Lewicki M, Sosnik A, Biglione M . Oral Pharmacokinetics of a Chitosan-Based Nano- Drug Delivery System of Interferon Alpha. Polymers (Basel). 2019; 11(11). PMC: 6918283. DOI: 10.3390/polym11111862. View

Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F . Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020; 6:14. PMC: 7073332. DOI: 10.1038/s41421-020-0153-3. View

Knuschke T, Rotan O, Bayer W, Kollenda S, Dickow J, Sutter K . Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8 T Cell Responses During Chronic Retroviral Infection. Front Immunol. 2018; 9:614. PMC: 5924795. DOI: 10.3389/fimmu.2018.00614. View

Zhu M, Wang R, Nie G . Applications of nanomaterials as vaccine adjuvants. Hum Vaccin Immunother. 2014; 10(9):2761-74. PMC: 4977448. DOI: 10.4161/hv.29589. View

Akerstrom S, Mousavi-Jazi M, Klingstrom J, Leijon M, Lundkvist A, Mirazimi A . Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005; 79(3):1966-9. PMC: 544093. DOI: 10.1128/JVI.79.3.1966-1969.2005. View

Cavalcanti I, Nogueira M . Pharmaceutical nanotechnology: which products are been designed against COVID-19?. J Nanopart Res. 2020; 22(9):276. PMC: 7480001. DOI: 10.1007/s11051-020-05010-6. View

10.

Kim E, Erdos G, Huang S, Kenniston T, Balmert S, Donahue Carey C . Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development. EBioMedicine. 2020; 55:102743. PMC: 7128973. DOI: 10.1016/j.ebiom.2020.102743. View

11.

Kong J, Wu K, Ji Y, Chen K, Zhang J, Sun H . Enhanced Bioavailability by Orally Administered Sirolimus Nanocrystals. ACS Appl Bio Mater. 2022; 2(10):4612-4621. DOI: 10.1021/acsabm.9b00695. View

12.

Widagdo W, Okba N, Li W, de Jong A, de Swart R, Begeman L . Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors. J Virol. 2019; 93(16). PMC: 6675889. DOI: 10.1128/JVI.00107-19. View

13.

Rodriguez-Teja M, Gronau J, Minamidate A, Darby S, Gaughan L, Robson C . Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147. Mol Cancer Res. 2014; 13(3):538-47. DOI: 10.1158/1541-7786.MCR-14-0344-T. View

14.

Dong L, Hu S, Gao J . Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020; 14(1):58-60. DOI: 10.5582/ddt.2020.01012. View

15.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

16.

Cojocaru F, Botezat D, Gardikiotis I, Uritu C, Dodi G, Trandafir L . Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics. 2020; 12(2). PMC: 7076512. DOI: 10.3390/pharmaceutics12020171. View

17.

Qiu G, Gai Z, Tao Y, Schmitt J, Kullak-Ublick G, Wang J . Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection. ACS Nano. 2020; 14(5):5268-5277. DOI: 10.1021/acsnano.0c02439. View

18.

Tavakol S, Hoveizi E, Kharrazi S, Tavakol B, Karimi S, Rezayat Sorkhabadi S . Organelles and chromatin fragmentation of human umbilical vein endothelial cell influence by the effects of zeta potential and size of silver nanoparticles in different manners. Artif Cells Nanomed Biotechnol. 2016; 45(4):817-823. DOI: 10.1080/21691401.2016.1178132. View

19.

Huy T, Thanh N, Thuy N, Chung P, Hung P, Le A . Cytotoxicity and antiviral activity of electrochemical - synthesized silver nanoparticles against poliovirus. J Virol Methods. 2017; 241:52-57. DOI: 10.1016/j.jviromet.2016.12.015. View

20.

Mohammadinejad R, Moosavi M, Tavakol S, Ozkan Vardar D, Hosseini A, Rahmati M . Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles. Autophagy. 2018; 15(1):4-33. PMC: 6287681. DOI: 10.1080/15548627.2018.1509171. View